Tobira Therapeutics is expanding its pipeline by being the partner of choice for suppliers, researchers, and alliance partners. A key component of Tobira’s strategy is to acquire global rights to additional product candidates in infectious diseases, while continuing to develop and commercialize new products and line extensions.

The Business Development team at Tobira is interested in identifying in-licensing candidates, as well as alliance and merger opportunities, that you may be aware of in infectious diseases arena. We are open to discussing products at all stages of development from late pre-clinical stage compounds to marketed products. We have established a program that provides significant compensation for any leads that are ultimately licensed by the company. To learn more about this program, please contact the Business Development team by sending an e-mail or filling out the form below.

Please direct Business Development inquiries to:

Robert Jacks
rjacks@tobiratherapeutics.com
Tel: 609-897-1102
www.tobiratherapeutics.com